financetom
Business
financetom
/
Business
/
Oil Gains on Supply Risks After Ukraine Attack, EIA Sees Prices Falling
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Gains on Supply Risks After Ukraine Attack, EIA Sees Prices Falling
Sep 12, 2025 6:14 AM

08:58 AM EDT, 09/12/2025 (MT Newswires) -- Oil prices rose early Friday, rebounding from the prior day's drop on oversupply worries, after a Ukrainian drone attack on a Russian oil-export port added a fresh risk premium.

West Texas Intermediate crude for October delivery was last seen up $1.38 at $63.75 a barrel, while November Brent oil gained $1.72 to $68.09.

The overnight strike on Russia's Primorsk oil port near St. Petersburg damaged the port and pipeline pumping stations, Bloomberg reported.

While it was unclear whether shipments from the Baltic port would be halted, the attack heightened supply concerns following an Israeli strike earlier this week on Hamas officials in Qatar.

"The support that geopolitical events provide to oil prices is finite. When tensions rise in oil-producing regions such as the Middle East or around Russia, the market's gut reaction is to cover short positions and build up some length. These moves are driven by perceptions, specifically, the belief that not only financial but, more importantly, physical oil supply will be adversely affected," PVM Oil Associates wrote.

The risk premium is offsetting warnings the oil market is over supplied. Both the International Energy Agency and the Energy Information Administration this week warned of rising global inventories as higher production from OPEC+ and producers in the Americas is pushing supply above demand, threatening to push prices lower.

"We expect the Brent crude oil price will decline significantly in the coming months, falling from $68 per barrel in August to $59 per barrel on average in the fourth quarter of 2025 and around $50 per barrel in early 2026," the EIA said in its monthly Short-Term Energy Outlook released Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved